Navigation Links
Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry

bles companies to achieve world-class business performance. By leveraging the comprehensive database of The Hackett Group, Answerthink's business and technology solutions help clients significantly improve performance and maximize returns on technology investments. Capabilities include benchmarking, business transformation, business applications, business intelligence, and offshore application development and support. Founded in 1997, Answerthink has offices throughout the United States and in Europe and Asia. Answerthink was named the SAP 2006 SME Partner of the Year.

About LORENZ Life Sciences Group

LORENZ Life Sciences Group (www.lorenz.cc) develops and markets software solutions for the Life Sciences market. LORENZ's solutions are geared specifically for submission assembly, review, publishing, validation and management. As the number one supplier of submission management systems in the world for US, European and Japanese submissions, LORENZ is currently the market leader in producing eCTDs. With over 100 installations in 20 countries, LORENZ has built a reputable customer base.

Copyright (C) 2007 Answerthink, Inc. All rights reserved. Answerthink and EzLifeSciences as well as their respective logos are trademarks or registered trademarks of Answerthink, Inc.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risks, uncertainties and other factors that may cause Answerthink's actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements. Factors that impact such forward-looking statements include, among others, the ability of the alliance or the products, services, or practices mentioned in this release to deliver the desired effect, our ability to effectively integrate acquisitions into our operations, our ability to
'"/>




Page: 1 2 3

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
7. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon
10. Oculus Innovative Sciences Microcyn Technology Presented in Poster at European Wound Management Association Conference
11. IR BioSciences Announces Promising Data from Study of Its Compound Homspera

Post Your Comments:
(Date:11/30/2009)...ire/ -- Breast-Specific Gamma Imaging (BSGI) has b...que for the detection of ductal carcinoma in situ ...I is a molecular breast imaging technique that can...cover very early stage cancers. According to findi...adiological Society of North America (RSNA), BSGI ...
(Date:11/30/2009)...0 Covance Inc. (NYSE: ...Piper Jaffray 21st Annual Health Care Conference o...Investors may access a live webcast of the present...and download any necessary software, please log on...s in Princeton, New Jersey, is one of the world,s ...
(Date:11/30/2009)...ire/ -- The Special Committee of Independent Direc...(TSX: PTI) and JLL Partners, Inc. and its affiliat..., today announced that the Company and JLL have en...e pending legal actions between the parties. ,...: ,, until March 2011, the Board will consist ...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3AUDIO from Medialink and Majestic Drug Company 3A When the Tooth Hurts 60261 1Just Released New Poll 3A Healthcare Through Womens Eyes 60259 1Just Released New Poll 3A Healthcare Through Womens Eyes 60259 2Shu Tung Li Founder and CEO of Collagen Matrix Inc Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest 60257 1Shu Tung Li Founder and CEO of Collagen Matrix Inc Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest 60257 2
...lysis showing,time to symptom resolution data from...daq: SHPGY) ulcerative colitis (UC) drug, LIALDA(T...eek (DDW). Study 302 (further,referred to as "Kamm...,Hospital in London, UK), demonstrated LIALDA was ...ctive, mild to moderate ulcerative colitis,compare...
... Could be Extended if Patients Receive the ...x, CHICAGO, May 20 Precision Therapeutics Inc. a...ased test that examines the,response of a specific...tes with significantly longer overall survival (OS...s who received a treatment determined by,ChemoFx t...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 6Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer 2Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer 3
(Date:12/1/2009)...und with elastography can help differentiate betwe... to a study presented today at the annual meeting ...). , "High-frequency ultrasound with elastograph...kin cancer diagnosis," said lead author Eliot L. S...diology at the University of Maryland School of Me...
(Date:12/1/2009)...d, controlled clinical trial presented today at th...rth America (RSNA) reveal that one in five patient...ly blood to the legs and other parts of the body a...sease. , Peripheral arterial disease (PAD) occu...and other substances, builds up in the arteries, l...
(Date:12/1/2009)... Adolescent obesity is a major public health prob...resulting in 4-5 million overweight youth in the U... 2009 issue of the Journal of the American Dietet... in weight control behaviors, including dietary in...dolescents who lost weight and those who did not i...
(Date:11/30/2009)...ast Fertility is attempting to dispel the notion t...and send patients home pregnant with multiples. W...ent, their priority is health and safety. In addi...hs can put on a country’s healthcare system...., 2009 -- Many patients and doctors in the U.K. wo...
(Date:11/30/2009)...wswire/ -- Results of a randomized, controlled cli...of the Radiological Society of North America (RSNA...or blockage in arteries that supply blood to the l...ant but silent coronary artery disease. ,, Per... a combination of fat, cholesterol and other subst...
Breaking Medicine News(10 mins):Health News:Special ultrasound accurately identifies skin cancer 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:Investigators identify successful weight control strategies for adolescents 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3
...who is president-elect of the Chicago Medical Soci...d work with lawmakers in the US on healthcare// re...be paid in cases of medical negligence. Shastr...e 3. Foremost on his agenda, he said, would ...
...eader Pramod Mahajan underwent a minor surgery on ...k after being shot at by his brother//. Doctors...olitician was rushed April 22 after Pravin Mahajan...r and a BJP general secretary, underwent a minor s...
...K has found that care home fees has increased by o... But in the concurrent period basic state pension ...said that the care home fees is bound to jump by a... capital above a certain limit get no help for the...
...(EMEA) has recommended the use of breast cancer dr...cord 27 days review//. A license for the drug is t... Institute of Health and Clinical Excellence in th...l be able to issue national guidance to the NHS on...
...called the Acomplia which the European Medicines A... for weight loss//. After this its shares rose 2.7...proved the drug for weight control. The chemical n...ommittee and FDA to make Acomplia available as an ...
...ultry from UK to prevent the spread of bird flu to...said in statement// as soon as the British ministr...ain of bird flu. This virus is less dangerous ...being spotted on another farm nearby in the easter...
Other Medicine News:Health News:Indian American Doctor Wants Healthcare Reforms 2Health News:Pramod Mahajan Undergoes Third Surgery 2
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: